Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Post by EbbFlow88on May 30, 2020 6:31pm
336 Views
Post# 31092469

Long time coming

Long time comingFinally had a chance to really go through the Q1 financials. This quarter proves what I have always said. This company's base business alone without all the extra expenses, is worth much more than what it is even trading at today.

Covid has forced Ceapro to limit certain expenses and focus mainly on their base business, and they walk away with a quartely profit of over $1 Million. Marketing and R&D expenses down, sales and profitabily up. This shows that the base business truly offers a risk/reward profile that has to be one of the best on the venture exchange.

The consultants was a nice boost to confidence in Gilles leadership and view for getting the company the best possible deal, which should be a huge boon for the share price and the company's future 

PGX's ability is also coming to fruition. It is enabling so many different projects that it is almost hard to keep track. The best part is there are highly intelligent teams or individuals looking at each end use. I truly cant wait to see what this deal looks like and who's involved.

My view on timing this investment has been way off, but looks like this is finally taking shape and will become massively profitable. Regardless, I see this as a great investment and fantastic risk/reward opportunity.

GLTA
Bullboard Posts